• Explore /
  • Poster
  • / Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): Depth of response and efficacy for selected subgroups in the lenvatinib (LEN) + pembrolizumab (PEMBRO) and sunitinib (SUN) treatment arms.

Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): Depth of response and efficacy for selected subgroups in the lenvatinib (LEN) + pembrolizumab (PEMBRO) and sunitinib (SUN) treatment arms.

Abstract Video & Slides Poster

Authors

Viktor Grünwald

Viktor Grünwald

University Hospital Essen, Essen, Germany

Viktor Grünwald , Thomas Powles , Evgeny Kopyltsov , Vadim Kozlov , Teresa Alonso Gordoa , Masatoshi Eto , Thomas E. Hutson , Robert J. Motzer , Eric Winquist , Pablo Maroto-Rey , Bhumsuk Keam , Giuseppe Procopio , Shirley Wong , Bohuslav Melichar , Frederic Rolland , Mototsugu Oya , Karla Rodriguez-Lopez , Kenichi Saito , Alan D. Smith , Camillo Porta

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT02811861

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4560)

DOI

10.1200/JCO.2021.39.15_suppl.4560

Abstract #

4560

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Sun Young Rha

First Author: Viktor Grünwald

First Author: Jaime Ivan Haro-Silerio

First Author: Richard S. Finn